266 related articles for article (PubMed ID: 6258421)
21. Serum angiotensin-converting-enzyme in Crohn's disease.
Nunez-Gornes JF; Tewksbury DA
Am J Gastroenterol; 1981 May; 75(5):384-5. PubMed ID: 6267935
[TBL] [Abstract][Full Text] [Related]
22. Cholelithiasis in inflammatory bowel disease. A case-control study.
Lorusso D; Leo S; Mossa A; Misciagna G; Guerra V
Dis Colon Rectum; 1990 Sep; 33(9):791-4. PubMed ID: 2202567
[TBL] [Abstract][Full Text] [Related]
23. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
24. Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy.
Kiernan MG; Coffey JC; Sahebally SM; Tibbitts P; Lyons EM; O'leary E; Owolabi F; Dunne CP
J Crohns Colitis; 2020 Jan; 14(1):118-129. PubMed ID: 31241755
[TBL] [Abstract][Full Text] [Related]
25. Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis.
Pruzanski W; Marcon N; Ottaway C; Prokipchuk E
Am J Dig Dis; 1977 Nov; 22(11):995-8. PubMed ID: 920710
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.
Fagan EA; Dyck RF; Maton PN; Hodgson HJ; Chadwick VS; Petrie A; Pepys MB
Eur J Clin Invest; 1982 Aug; 12(4):351-9. PubMed ID: 6814926
[TBL] [Abstract][Full Text] [Related]
27. Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis.
Jaszewski R; Tolia V; Ehrinpreis MN; Bodzin JH; Peleman RR; Korlipara R; Weinstock JV
Gastroenterology; 1990 Jun; 98(6):1543-8. PubMed ID: 2159930
[TBL] [Abstract][Full Text] [Related]
28. Monocytes in inflammatory bowel disease: monocyte and serum lysosomal enzyme activity.
Mee AS; Jewell DP
Clin Sci (Lond); 1980 Apr; 58(4):295-300. PubMed ID: 7379454
[TBL] [Abstract][Full Text] [Related]
29. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease.
Klockars M; Reitamo S; Reitamo JJ; Möller C
Gut; 1977 May; 18(5):377-81. PubMed ID: 326636
[TBL] [Abstract][Full Text] [Related]
31. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
32. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
33. Crohn's disease and ulcerative colitis in the same patient.
White CL; Hamilton SR; Diamond MP; Cameron JL
Gut; 1983 Sep; 24(9):857-62. PubMed ID: 6884819
[TBL] [Abstract][Full Text] [Related]
34. Serum nitrate levels in ulcerative colitis and Crohn's disease.
Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
[TBL] [Abstract][Full Text] [Related]
35. Zinc status in inflammatory bowel disease.
Ainley CC; Cason J; Carlsson LK; Slavin BM; Thompson RP
Clin Sci (Lond); 1988 Sep; 75(3):277-83. PubMed ID: 3416562
[TBL] [Abstract][Full Text] [Related]
36. Serum lysozyme levels in Crohn's disease and ulcerative colitis.
Peeters TL; Vantrappen G; Geboes K
Gut; 1976 Apr; 17(4):300-5. PubMed ID: 773792
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease.
Aldebert D; Masy E; Reumaux D; Lion G; Colombel JF; Duthilleul P
Dig Dis Sci; 1997 Nov; 42(11):2350-5. PubMed ID: 9398816
[TBL] [Abstract][Full Text] [Related]
38. Serum angiotensin I-converting enzyme is reduced in Crohn's disease and ulcerative colitis irrespective of genotype.
Matsuda T; Suzuki J; Furuya K; Masutani M; Kawakami Y
Am J Gastroenterol; 2001 Sep; 96(9):2705-10. PubMed ID: 11569699
[TBL] [Abstract][Full Text] [Related]
39. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
Thompson JS; Burnett DA; Markin RS; Vaughan WP
Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
[TBL] [Abstract][Full Text] [Related]
40. Mucosal glucosamine synthetase activity in inflammatory bowel disease.
Winslet MC; Poxon V; Allan A; Keighley MR
Dig Dis Sci; 1994 Mar; 39(3):540-4. PubMed ID: 8131690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
